Richard P. Slaughter Associates’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-109,155
Closed -$1.12M 149
2023
Q3
$1.12M Buy
109,155
+23,517
+27% +$290K 0.3% 94
2023
Q2
$1.18M Buy
85,638
+417
+0.5% +$6.26K 0.34% 91
2023
Q1
$1.38M Sell
85,221
-263
-0.3% -$4.95K 0.45% 71
2022
Q4
$1.51M Sell
85,484
-429
-0.5% -$8.52K 0.48% 64
2022
Q3
$1.68M Buy
85,913
+18,067
+27% +$384K 0.7% 46
2022
Q2
$1.35M Buy
67,846
+2,500
+4% +$55.9K 0.59% 58
2022
Q1
$1.69M Buy
65,346
+3,581
+6% +$92.9K 0.62% 56
2021
Q4
$1.56M Sell
61,765
-3,123
-5% -$86.4K 0.55% 59
2021
Q3
$1.74M Buy
+64,888
New +$1.87M 0.69% 55

Other funds holding PETS

Richard P. Slaughter Associates's PETS Position: Q4 2023 in Review

Richard P. Slaughter Associates sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 109,155 shares — an estimated $1.12M sold.

Richard P. Slaughter Associates first reported a position in PETS in Q3 2021 and held it in 9 quarters. The position peaked at $1.74M in Q3 2021. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

  • Richard P. Slaughter Associates reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
  • Richard P. Slaughter Associates sold 109,155 PetMed Express shares in Q4 2023, an estimated $1.12M.
  • Richard P. Slaughter Associates first reported a position in PetMed Express in Q3 2021 and held it in 9 quarters.
  • Richard P. Slaughter Associates's PetMed Express position peaked at $1.74M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Richard P. Slaughter Associates's 13F filing for Q4 2023, filed 8 Jan 2024.